In February, the biosciences company Arcadia received an $855,500 grant to enter the second phase of developing wheat varieties with reduced celiac disease-causing proteins. The grant, from NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the American Recovery and Reinvestment Act (ARRA), is in collaboration with Washington State University, and will last for two-years. According to the press release, Phase I of the research successfully identified"wheat plants with low levels of proteins that are most toxic to individuals with celiac disease." Phase II is expected to last through mid-2011.
All indications are that gluten-free wheat will be available to our kids sometime in the not so distant future.